What is ResMed's long-term debt?

ResMed (RMD) reported long-term debt of $664.1M in Q1 2026.

How has ResMed's long-term debt changed year-over-year?

ResMed's long-term debt decreased by 1.3% year-over-year, from $673.03M to $664.1M.

What is the long-term trend for ResMed's long-term debt?

Over 4 years (2021 to 2025), ResMed's long-term debt has grown at a 0.5% compound annual growth rate (CAGR), from $655.35M to $668.29M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

ResMed RMD Long-Term Debt

Long-Term Debt at other companies

Eli LillyLLY

$39.37B+14.1%

Five Point Holdings, Inc.FPH

$444.05M-15.8%

Viemed Healthcare, Inc.VMD

$8.33M+136%

LivaNovaLIVN

$285.16M-48.1%

Pulmonx CorporationLUNG

$37.21M+26.6%

AdaptHealthAHCO

$1.8B-7.3%

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$30.31B-23.6%

Enterprise value$29.75B-24.3%

P/E20×-8.4×

P/S5.5×-2.2×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:DebtLongtermAndShorttermCombinedAmount.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's long-term debt?: ResMed (RMD) reported long-term debt of $664.1M in Q1 2026.
How has ResMed's long-term debt changed year-over-year?: ResMed's long-term debt decreased by 1.3% year-over-year, from $673.03M to $664.1M.
What is the long-term trend for ResMed's long-term debt?: Over 4 years (2021 to 2025), ResMed's long-term debt has grown at a 0.5% compound annual growth rate (CAGR), from $655.35M to $668.29M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.